The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Index level declines can reflect profit-taking, macro shocks, or sector rotations. This intro covers common indicators to read with context.
23,215 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
JPMorgan’s Dividend Leaders ETF shows a surprising income mismatch, posting a 1.59% yield while Treasuries offer more...
A 73-year-old worker with an $800,000 401(K) cannot roll it into a new IRA after leaving a former employer, revealing...
Nuclear energy is attracting new attention from investors. This guide compares NuScale Power and Constellation Energy...
The FHFA has directed Fannie Mae to accept cryptocurrency as mortgage reserves, but a steep haircut on crypto holding...
This week brought a sharp decline in lenz therapeutics stock plummeted as concerns about revenue growth and financing...
A $295 million crypto hack shook a Solana-based exchange. This article explains how solana exchange drift plans to co...
A Layer-3 token listed on South Korea's Upbit surged in minutes, triggering a rapid rally described by traders as a v...
This comprehensive guide breaks down Exzeo’s Q1 2026 results, reveals the drivers behind exzeo (xzo) 2026 earnings, a...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...
A sweeping housing proposal could unlock an easier path to ownership for many Americans. This guide breaks down what ...
In healthcare robotics, durable moats matter as much as dazzling tech. This article breaks down why intuitive surgica...